Sabra CEO plans $4.15M sale of 200,000 shares

Sabra Health Care REIT, Inc. (SBRA) discloses that its CEO, Richard K. Matros, has filed a notice of proposed sale under Rule 144 for up to 200,000 shares of common stock through Merrill Lynch.

Rhea-AI Filing Summary

Sabra Health Care REIT, Inc. (SBRA) discloses that its CEO, Richard K. Matros, has filed a notice of proposed sale under Rule 144 for up to 200,000 shares of common stock through Merrill Lynch. The shares have an aggregate market value of $4,150,000 and are part of a share class with 255,462,756 shares outstanding, with sales expected to begin on or about September 8, 2026 on NASDAQ. The notice identifies multiple underlying awards classified as Restricted Stock Units originally granted between 2013 and 2017, including blocks of 7,514 and 29,020 shares, each indicated for cash settlement on September 8, 2026.

Key Figures

Shares to be sold under Rule 144: 200,000 shares Aggregate market value of planned sale: $4,150,000 Shares outstanding: 255,462,756 shares +3 more

6 metrics

Shares to be sold under Rule 144 200,000 shares Planned common stock sale by CEO through Merrill Lynch

Aggregate market value of planned sale $4,150,000 Total market value of 200,000 shares covered by the notice

Shares outstanding 255,462,756 shares Common stock outstanding at time of notice

Approximate date of sale September 8, 2026 Planned start date for sales on NASDAQ

Restricted Stock Units example 1 7,514 shares RSUs from March 15, 2013 grant indicated for cash settlement on September 8, 2026

Restricted Stock Units example 2 29,020 shares RSUs from January 10, 2014 grant indicated for cash settlement on September 8, 2026

Key Terms

Rule 144, Restricted Stock Units, aggregate market value, securities to be sold

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Common | 03/15/2013 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

aggregate market value financial

"200000 | 4150000 | 255462756 | 09/08/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

securities to be sold financial

"144: Securities To Be Sold"

FAQ

What does the Form 144 filing disclose for Sabra Health Care REIT (SBRA)?

It discloses that CEO Richard K. Matros filed a Rule 144 notice to potentially sell 200,000 shares of SBRA common stock, with an aggregate market value of $4,150,000, through Merrill Lynch, with sales expected to begin on or about September 8, 2026 on NASDAQ.

How many Sabra Health Care REIT (SBRA) shares are covered by this Rule 144 notice?

The notice covers up to 200,000 shares of Sabra Health Care REIT common stock. These shares are planned to be sold through Merrill Lynch and are associated with previously granted Restricted Stock Units to CEO Richard K. Matros.

What is the aggregate market value of the SBRA shares in this planned Rule 144 sale?

The filing lists an aggregate market value of $4,150,000 for the 200,000 shares of Sabra Health Care REIT common stock covered by the Rule 144 notice. This figure is reported in the securities information section.

When may the CEO of SBRA begin selling shares under this Form 144?

The filing states an approximate sale date of September 8, 2026. Several underlying Restricted Stock Unit awards are also shown with a September 8, 2026 date for cash settlement, aligning with the planned sale timing.

How many Sabra Health Care REIT (SBRA) shares are outstanding according to this filing?

The securities information section reports 255,462,756 shares outstanding of Sabra Health Care REIT common stock. This provides context for the 200,000 shares referenced in the Rule 144 sale notice.

What types of awards underlie the SBRA shares to be sold by the CEO?

The shares are tied to multiple Restricted Stock Units granted by the issuer between 2013 and 2017. Examples include 7,514 shares from a March 15, 2013 grant and 29,020 shares from a January 10, 2014 grant, each indicated for cash settlement on September 8, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 11:41 AM Accepted by SEC EDGAR 09/08/2026 - 11:41 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001184158
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Sabra Health Care Reit
SEC File Number	001-34950
Address of Issuer	1781 Flight Way Tustin CALIFORNIA 92782
Phone	1-888-393-8248
Name of Person for Whose Account the Securities are To Be Sold	Richard K. Matros
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	CEO

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch One Bryant Park, 28th Floor New York NY 10036	200000	4150000	255462756	09/08/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/15/2013	Restricted Stock Units	Issuer			7514	09/08/2026	Cash
Common	01/10/2014	Restricted Stock Units	Issuer			29020	09/08/2026	Cash
Common	12/31/2014	Restricted Stock Units	Issuer			73520	09/08/2026	Cash
Common	01/09/2015	Restricted Stock Units	Issuer			5750	09/08/2026	Cash
Common	01/14/2015	Restricted Stock Units	Issuer			8455	09/08/2026	Cash
Common	02/12/2015	Restricted Stock Units	Issuer			65641	09/08/2026	Cash
Common	03/01/2017	Restricted Stock Units	Issuer			10100	09/08/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/08/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/08/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Richard K. Matros
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)